BCG | Polio 0 | Polio 1 | Polio 2 | Polio 3 | Penta 1 | Penta 2 | Penta 3 | Measles 1 | Measles 2 | |
No of eligible subjects to be vaccinated | 1143 | 1143 | 1076 | 1035 | 1016 | 1076 | 1035 | 1016 | 649 | 419 |
No of vaccinated subjects (N) | 1143 | 1143 | 1088 | 1041 | 1021 | 1086 | 1040 | 1019 | 1010 | 938 |
Early (%) | – | – | 19.9 | 13.9 | 11.2 | 19.9 | 14.9 | 11.4 | 92.9 | 94.8 |
Timely (%) | 89.3 | 87.7 | 62.8 | 57.2 | 46.2 | 61.0 | 55.5 | 45.2 | 2.7 | 3.3 |
Delayed (%) | 10.7 | 12.3 | 17.3 | 28.9 | 42.6 | 19.1 | 29.6 | 43.4 | 4.5 | 1.9 |
BCG, bacillus Calmette-Guérin; Polio, oral polio vaccine; Penta, diphtheria tetanus pertussis–hepatitis B–Haemophilus influenza type b.